Hemcheck Sweden AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hemcheck Sweden AB with three other
pharmaceutical manufacturers in Europe:
IGEA Pharma NV
of NETHERLANDS
(2017
sales of 6,844.67 Euros [US$7,977.47 ]
),
Oncoarendi Therapeutics SA
of POLAND
(6,000.00 Polish New Zlotys [US$1,549.20 ]
), and
Irlab Therapeutics Ab
(109,000.00 Swedish Kronor [US$12,083.74 ]
).
Sales Analysis.